Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Leukemia, Myeloid, Acute 2Osteoarthritis 1Lymphoma, B-Cell 1Low Back Pain 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1Cancer Pain 1

Interventions

rofecoxib 1acetaminophen, codeine drug combination 1World Health Organization oral rehydration solution 1Vitamin D 1Syringes 1Oxycodone 1Nutrition Assessment 1Naloxone 1Inosine Monophosphate 1Injections, Intra-Articular 1Fish Oils 1Fatty Acids, Omega-3 1Eicosapentaenoic Acid 1Duration of Therapy 1Docosahexaenoic Acids 1Cholecalciferol 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoarthritis × Inosine Monophosphate × Clear all
NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed
4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡